Clariane SE (XPAR:CLARI)
€ 4.004 -0.092 (-2.25%) Market Cap: 1.43 Bil Enterprise Value: 8.66 Bil PE Ratio: 117.76 PB Ratio: 0.39 GF Score: 58/100

Half Year 2026 Clariane SE Earnings Call Transcript

Jul 30, 2026 / 01:00 PM GMT
Release Date Price: €4.13 (+2.02%)

Key Points

Positve
  • Clariane SE (KRNMF) delivered a strong 14.9% pro forma increase in pre-IFRS 16 EBITDA, with the margin improving by 90 basis points to 10.4%, driven by higher volumes, active case mix management, and cost efficiency programs.
  • The company successfully completed over EUR1 billion in refinancing transactions, simplifying its capital structure, extending debt maturities beyond 2030, and securing a robust liquidity position of EUR1.7 billion.
  • Occupancy rates in medicalized nursing homes improved by 1.2 percentage points to 91.7%, with management expecting continued annual gains of 100-150 basis points, supported by strong demographic demand.
  • Operating cash flow increased by 8.3% to EUR144 million, and net free cash flow improved significantly to near breakeven, aligning with the company's ambition to turn cash flow positive in 2026.
  • The company confirmed its medium-term outlook, targeting average annual pro forma EBITDA growth of 7%-9% and OPCO EBITDA growth of 11%-14% through 2028, supported by a clear operational roadmap and disciplined capital allocation.
Negative
  • Net financial debt remained high at over EUR3 billion, with pro forma whole-co leverage at 5.4 times, though management targets a reduction to around 5 times by 2028.
  • The company incurred EUR51 million in exceptional costs related to restructuring and disposal transactions, which weighed on net profit attributable to the group.
  • Organic revenue growth slowed sequentially to 4.6% from 4.9% in Q1, partly due to a tough comparison base from the prior year's flu season and a moderation in German pricing effects.
  • Cost inflation, particularly in France and Germany, amounted to EUR50 million, partially offsetting the positive impact of price and tariff increases on EBITDA.
  • The real estate portfolio saw a EUR60 million negative impact from a slight increase in the average capitalization rate to 6.6%, limiting the growth in gross asset value.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CLARI.PA - Clariane SE
Half Year 2026 Clariane SE Earnings Call
Jul 30, 2026 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to the Clarion 2026 half-year results presentation. For the first part of the conference call, participants will be in listen-only mode. However, during the questions and answers session, participants are able to ask questions. This can be done by dialing pound key five on their telephone keypad or by typing a question in the chat box. Now I will hand the conference over to the management team. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you very much. Ladies and gentlemen, dear investors and financial partners, good afternoon and welcome to The Clarion
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot